Vaccines Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Vaccines stocks.

Vaccines Stocks Recent News

Date Stock Title
Nov 21 MRK Merck & Co., Inc. (MRK) Jefferies London Healthcare Conference
Nov 21 MRNA Major companies that are also popular short-selling stocks
Nov 21 MRK Merck Data at the ASH 2024 Annual Meeting Highlights Promising Hematology Pipeline With Diverse Range of Investigational Assets and Novel Modalities
Nov 21 MRK Keytruda represents almost half of Merck’s sales, and a new formulation could fend off rivals
Nov 20 MRNA CDC warns of an imminent spike in COVID, flu cases
Nov 20 MRK Merck Foundation Announces $17 Million U.S. Initiative To Expand Access to High-Quality Cardiac Care
Nov 20 MRK Merck & Co., Inc. (MRK)’s Blockbuster Drugs: A Key Player in Ken Griffin’s Portfolio
Nov 20 NVAX Novavax, Inc. (NVAX) Jefferies London Healthcare Conference (Transcript)
Nov 20 MRNA Moderna initiated with a Hold at Berenberg
Nov 19 MRK Merck readies new Keytruda version ahead of major regulatory headwinds
Nov 19 MRK Merck's Multi-Billion Dollar Drug Keytruda's Investigational Under The Skin Injection At Par With Intravenous Formulation In Untreated Lung Cancer Patients
Nov 19 MRNA BioNTech started at buy, Moderna at hold by Berenberg
Nov 19 MRK Merck raises dividend to $0.81/share
Nov 19 MRK Merck Announces First-Quarter 2025 Dividend
Nov 19 MRK Merck: Seriously Undervalued At Peak Pessimism (Rating Upgrade)
Nov 19 AGEN Agenus (AGEN) Loses -41.56% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Nov 19 VXRT Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 19 MRK Merck says injectable Keytruda succeeded in late-stage trial
Nov 19 MRK Under-the-skin Keytruda comparable to infused version in Phase 3 study, Merck says
Nov 19 MRK Merck Announces Phase 3 Trial of Subcutaneous Pembrolizumab With Berahyaluronidase Alfa Met Primary Endpoints
Vaccines

A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and to further recognize and destroy any of the microorganisms associated with that agent that it may encounter in the future. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by a natural or "wild" pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).The administration of vaccines is called vaccination. Vaccination is the most effective method of preventing infectious diseases; widespread immunity due to vaccination is largely responsible for the worldwide eradication of smallpox and the restriction of diseases such as polio, measles, and tetanus from much of the world.
The effectiveness of vaccination has been widely studied and verified; for example, vaccines that have proven effective include the influenza vaccine, the HPV vaccine, and the chicken pox vaccine. The World Health Organization (WHO) reports that licensed vaccines are currently available for twenty-five different preventable infections.The terms vaccine and vaccination are derived from Variolae vaccinae (smallpox of the cow), the term devised by Edward Jenner to denote cowpox. He used it in 1798 in the long title of his Inquiry into the Variolae vaccinae known as the Cow Pox, in which he described the protective effect of cowpox against smallpox. In 1881, to honor Jenner, Louis Pasteur proposed that the terms should be extended to cover the new protective inoculations then being developed.

Browse All Tags